IFNG and cancer: This bacterium was previously identified as an “oncomicrobiotic” due to its capacity to promote the infiltration of IFN-γ–producing γδT cells in cancer lesions, which can ameliorate the efficacy of the anti-cancer immunomodulatory agent cyclophosphamide (Daillère et al., 2016).